Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Huston MW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monteferrario D; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., David M; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Tadi SK; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Zhou Y; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Marchetti I; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Jeanneau C; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Saviane G; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Dupont CF; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Martelli AE; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Truong LN; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Eshleman JA; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Ng CC; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Huston MW; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Davis GD; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Fontenot JD; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Reik A; Sangamo Therapeutics, 501 Canal Boulevard, Richmond, CA 94804, USA., Rosa M; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France., Fenard D; Sangamo Therapeutics France, Allée de la Nertière, F-06560 Valbonne, Sophia-Antipolis, France.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Apr 24; Vol. 32 (2), pp. 101255. Date of Electronic Publication: 2024 Apr 24 (Print Publication: 2024).
Autor:
Pagant S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Huston MW; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Moreira L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Gan L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., St Martin S; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Sproul S; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Holmes MC; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Meyer K; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Wechsler T; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Desnick RJ; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Yasuda M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: makiko.yasuda@mssm.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Nov 03; Vol. 29 (11), pp. 3230-3242. Date of Electronic Publication: 2021 Mar 26.
Autor:
Yasuda M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Huston MW; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Pagant S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gan L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., St Martin S; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Sproul S; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Richards D; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Ballaron S; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Hettini K; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Ledeboer A; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Falese L; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Cao L; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Lu Y; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Holmes MC; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Meyer K; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA., Desnick RJ; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wechsler T; Sangamo Therapeutics, Inc., Brisbane, CA 94005, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 Jul 09; Vol. 18, pp. 607-619. Date of Electronic Publication: 2020 Jul 09 (Print Publication: 2020).
Autor:
Stok M; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Pediatrics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Center for Lysosomal and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., de Boer H; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Molecular Stem Cell Biology, Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Huston MW; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Jacobs EH; Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Roovers O; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Visser TP; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Jahr H; Department of Orthopaedics, Erasmus University Medical Center, Rotterdam, the Netherlands., Duncker DJ; Division of Experimental Cardiology, Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands., van Deel ED; Division of Experimental Cardiology, Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Reuser AJJ; Center for Lysosomal and Metabolic Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.; Molecular Stem Cell Biology, Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., van Til NP; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Wagemaker G; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 May 04; Vol. 17, pp. 1014-1025. Date of Electronic Publication: 2020 May 04 (Print Publication: 2020).
Autor:
Yadak R; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Cabrera-Pérez R; Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Barcelona, Catalonia, Spain., Torres-Torronteras J; Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Barcelona, Catalonia, Spain., Bugiani M; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands., Haeck JC; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Huston MW; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bogaerts E; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Goffart S; Department of Biology, University of Eastern Finland, Joensuu, Finland., Jacobs EH; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Stok M; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Pediatrics, Erasmus University Medical Center, Rotterdam, the Netherlands., Leonardelli L; San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy., Biasco L; San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy.; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; University College of London (UCL), Great Ormond Street Institute of Child Health (ICH), London, UK., Verdijk RM; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bernsen MR; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Ruijter G; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands., Martí R; Research Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Barcelona, Catalonia, Spain., Wagemaker G; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Hacettepe University, Stem Cell Research and Development Center, Ankara, Turkey.; Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology and Hematology, Saint Petersburg, Russia., van Til NP; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., de Coo IFM; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2018 Jan 08; Vol. 8, pp. 152-165. Date of Electronic Publication: 2018 Jan 08 (Print Publication: 2018).
Autor:
Huston MW; 1 Department of Neurology, Erasmus University Medical Center , 3000 CA Rotterdam, The Netherlands ., Riegman AR, Yadak R, van Helsdingen Y, de Boer H, van Til NP, Wagemaker G
Publikováno v:
Human gene therapy [Hum Gene Ther] 2014 Oct; Vol. 25 (10), pp. 905-14.
Autor:
Huston MW; Department of Hematology, Erasmus University Medical Center, GE Rotterdam, The Netherlands., Brugman MH, Horsman S, Stubbs A, van der Spek P, Wagemaker G
Publikováno v:
Human gene therapy [Hum Gene Ther] 2012 Nov; Vol. 23 (11), pp. 1209-19. Date of Electronic Publication: 2012 Sep 27.
Autor:
Huston MW; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., van Til NP, Visser TP, Arshad S, Brugman MH, Cattoglio C, Nowrouzi A, Li Y, Schambach A, Schmidt M, Baum C, von Kalle C, Mavilio F, Zhang F, Blundell MP, Thrasher AJ, Verstegen MM, Wagemaker G
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2011 Oct; Vol. 19 (10), pp. 1867-77. Date of Electronic Publication: 2011 Jul 12.